.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Covington
Merck
US Department of Justice
Johnson and Johnson
Julphar
Deloitte
Queensland Health
Colorcon

Generated: November 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019697

« Back to Dashboard
NDA 019697 describes ORTHO TRI-CYCLEN, which is a drug marketed by Janssen Pharms and is included in two NDAs. It is available from two suppliers. There is one patent protecting this drug. Additional details are available on the ORTHO TRI-CYCLEN profile page.

The generic ingredient in ORTHO TRI-CYCLEN is ethinyl estradiol; norgestimate. There are twenty-six drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norgestimate profile page.

Summary for 019697

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 019697

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ORTHO TRI-CYCLEN
ethinyl estradiol; norgestimate
TABLET;ORAL-21 019697 NDA Rebel Distributors Corp 21695-407 21695-407-01 6 DIALPACK in 1 CARTON (21695-407-01) > 1 KIT in 1 DIALPACK
ORTHO TRI-CYCLEN
ethinyl estradiol; norgestimate
TABLET;ORAL-21 019697 NDA Physicians Total Care, Inc. 54868-5826 54868-5826-0 1 DIALPACK in 1 CARTON (54868-5826-0) > 1 KIT in 1 DIALPACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORAL-28Strength0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG
Approval Date:Jul 3, 1992TE:ABRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORAL-21Strength0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG
Approval Date:Jul 3, 1992TE:RLD:No

Expired Orange Book Patents for NDA: 019697

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Pharms
ORTHO TRI-CYCLEN
ethinyl estradiol; norgestimate
TABLET;ORAL-21019697-002Jul 3, 1992► Subscribe► Subscribe
Janssen Pharms
ORTHO TRI-CYCLEN
ethinyl estradiol; norgestimate
TABLET;ORAL-21019697-002Jul 3, 1992► Subscribe► Subscribe
Janssen Pharms
ORTHO TRI-CYCLEN
ethinyl estradiol; norgestimate
TABLET;ORAL-21019697-002Jul 3, 1992► Subscribe► Subscribe
Janssen Pharms
ORTHO TRI-CYCLEN
ethinyl estradiol; norgestimate
TABLET;ORAL-28019697-001Jul 3, 1992► Subscribe► Subscribe
Janssen Pharms
ORTHO TRI-CYCLEN
ethinyl estradiol; norgestimate
TABLET;ORAL-28019697-001Jul 3, 1992► Subscribe► Subscribe
Janssen Pharms
ORTHO TRI-CYCLEN
ethinyl estradiol; norgestimate
TABLET;ORAL-28019697-001Jul 3, 1992► Subscribe► Subscribe
Janssen Pharms
ORTHO TRI-CYCLEN
ethinyl estradiol; norgestimate
TABLET;ORAL-28019697-001Jul 3, 1992► Subscribe► Subscribe
Janssen Pharms
ORTHO TRI-CYCLEN
ethinyl estradiol; norgestimate
TABLET;ORAL-28019697-001Jul 3, 1992► Subscribe► Subscribe
Janssen Pharms
ORTHO TRI-CYCLEN
ethinyl estradiol; norgestimate
TABLET;ORAL-21019697-002Jul 3, 1992► Subscribe► Subscribe
Janssen Pharms
ORTHO TRI-CYCLEN
ethinyl estradiol; norgestimate
TABLET;ORAL-21019697-002Jul 3, 1992► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Deloitte
Accenture
Boehringer Ingelheim
Novartis
UBS
Johnson and Johnson
Harvard Business School
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot